Scorpion Therapeutics is a private drug discovery company. It has raised $150 million across 3 recorded rounds; the latest was a $150 million Series C in Jul 2024.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$150.0M
Last round
Later Stage VC (Series C)
Jul 2024
Investors — not yet on record
No investors in Scorpion Therapeutics are on record yet. Backers surface from round announcements, filings, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Scorpion Therapeutics with a free account
·Watch Scorpion Therapeutics: the Monday email on marks, rounds and moves
